WallStreetZenWallStreetZen

NASDAQ: ALVO
Alvotech Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for ALVO

Based on 1 analyst offering 12 month price targets for Alvotech.
Min Forecast
$18.00+64.84%
Avg Forecast
$18.00+64.84%
Max Forecast
$18.00+64.84%

Should I buy or sell ALVO stock?

Based on 1 analyst offering ratings for Alvotech.
Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ALVO stock forecasts and price targets.

ALVO stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-07-25

1 of 1

Forecast return on equity

Is ALVO forecast to generate an efficient return?
Company
-32.84%
Industry
37.1%
Market
58.16%
ALVO's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is ALVO forecast to generate an efficient return on assets?
Company
18.62%
Industry
15.92%
ALVO is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ALVO earnings per share forecast

What is ALVO's earnings per share in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
-$0.66
Avg 2 year Forecast
-$0.02
Avg 3 year Forecast
$0.26

ALVO revenue forecast

What is ALVO's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$245.9M-20.35%
Avg 2 year Forecast
$679.5M+120.09%
Avg 3 year Forecast
$953.2M+208.75%
ALVO's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

ALVO revenue growth forecast

How is ALVO forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?
Company
47.62%
Industry
6.42%
Market
9.32%
ALVO's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ALVO's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ALVO vs Pharmaceutical Stocks

TickerPricePrice TargetUp/downsideConsensus
ALVO$10.92$18.00+64.84%Strong Buy
HCM$16.03$19.00+18.53%Hold
AMRX$8.38$9.00+7.40%Strong Buy
PBH$72.11$87.50+21.34%Strong Buy
PRGO$27.15$38.50+41.80%Strong Buy
View Top Pharmaceutical Stocks

Alvotech Stock Forecast FAQ

Is Alvotech Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: ALVO) stock is to Strong Buy ALVO stock.

Out of 1 analyst, 1 (100%) are recommending ALVO as a Strong Buy, 0 (0%) are recommending ALVO as a Buy, 0 (0%) are recommending ALVO as a Hold, 0 (0%) are recommending ALVO as a Sell, and 0 (0%) are recommending ALVO as a Strong Sell.

If you're new to stock investing, here's how to buy Alvotech stock.

What is ALVO's earnings growth forecast for 2024-2026?

(NASDAQ: ALVO) Alvotech's forecast annual earnings growth rate of N/A is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast earnings growth rate of 21.17%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 16.98%.

Alvotech's earnings in 2024 is -$618,381,000.On average, 2 Wall Street analysts forecast ALVO's earnings for 2024 to be -$185,135,753, with the lowest ALVO earnings forecast at -$272,450,758, and the highest ALVO earnings forecast at -$97,792,806. On average, 2 Wall Street analysts forecast ALVO's earnings for 2025 to be -$6,063,154, with the lowest ALVO earnings forecast at -$26,068,768, and the highest ALVO earnings forecast at $13,970,401.

In 2026, ALVO is forecast to generate $73,679,894 in earnings, with the lowest earnings forecast at $73,679,894 and the highest earnings forecast at $73,679,894.

What is ALVO's revenue growth forecast for 2024-2026?

(NASDAQ: ALVO) Alvotech's forecast annual revenue growth rate of 47.62% is forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 6.42%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.32%.

Alvotech's revenue in 2024 is $308,729,000.On average, 1 Wall Street analysts forecast ALVO's revenue for 2024 to be $68,706,431,626, with the lowest ALVO revenue forecast at $68,706,431,626, and the highest ALVO revenue forecast at $68,706,431,626. On average, 2 Wall Street analysts forecast ALVO's revenue for 2025 to be $189,848,527,766, with the lowest ALVO revenue forecast at $181,615,211,700, and the highest ALVO revenue forecast at $198,082,123,241.

In 2026, ALVO is forecast to generate $266,335,075,654 in revenue, with the lowest revenue forecast at $266,335,075,654 and the highest revenue forecast at $266,335,075,654.

What is ALVO's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: ALVO) forecast ROA is 18.62%, which is higher than the forecast US Drug Manufacturers - Specialty & Generic industry average of 15.92%.

What is ALVO's Price Target?

According to 1 Wall Street analyst that have issued a 1 year ALVO price target, the average ALVO price target is $18.00, with the highest ALVO stock price forecast at $18.00 and the lowest ALVO stock price forecast at $18.00.

The Wall Street analyst predicted that Alvotech's share price could reach $18.00 by Jul 25, 2025. The average Alvotech stock price prediction forecasts a potential upside of 64.84% from the current ALVO share price of $10.92.

What is ALVO's Earnings Per Share (EPS) forecast for 2024-2026?

(NASDAQ: ALVO) Alvotech's current Earnings Per Share (EPS) is -$2.65. On average, analysts forecast that ALVO's EPS will be -$0.66 for 2024, with the lowest EPS forecast at -$0.98, and the highest EPS forecast at -$0.35. On average, analysts forecast that ALVO's EPS will be -$0.02 for 2025, with the lowest EPS forecast at -$0.09, and the highest EPS forecast at $0.05. In 2026, ALVO's EPS is forecast to hit $0.26 (min: $0.26, max: $0.26).

What is ALVO's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: ALVO) forecast ROE is -32.84%, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.